Literature DB >> 12427740

The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.

Francois Fuks1, Paul J Hurd, Daniel Wolf, Xinsheng Nan, Adrian P Bird, Tony Kouzarides.   

Abstract

DNA methylation plays an important role in mammalian development and correlates with chromatin-associated gene silencing. The recruitment of MeCP2 to methylated CpG dinucleotides represents a major mechanism by which DNA methylation can repress transcription. MeCP2 silences gene expression partly by recruiting histone deacetylase (HDAC) activity, resulting in chromatin remodeling. Here, we show that MeCP2 associates with histone methyltransferase activity in vivo and that this activity is directed against Lys(9) of histone H3. Two characterized repression domains of MeCP2 are involved in tethering the histone methyltransferase to MeCP2. We asked if MeCP2 can deliver Lys(9) H3 methylation to the H19 gene, whose activity it represses. We show that the presence of MeCP2 on nucleosomes within the repressor region of the H19 gene (the differentially methylated domain) coincides with an increase in H3 Lys(9) methylation. Our data provide evidence that MeCP2 reinforces a repressive chromatin state by acting as a bridge between two global epigenetic modifications, DNA methylation and histone methylation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427740     DOI: 10.1074/jbc.M210256200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  302 in total

1.  The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.

Authors:  François Fuks; Paul J Hurd; Rachel Deplus; Tony Kouzarides
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

2.  Epigenetic asymmetry in the mammalian zygote and early embryo: relationship to lineage commitment?

Authors:  Wolf Reik; Fatima Santos; Kohzoh Mitsuya; Hugh Morgan; Wendy Dean
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-08-29       Impact factor: 6.237

3.  A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.

Authors:  Slimane Ait-Si-Ali; Valentina Guasconi; Lauriane Fritsch; Hakima Yahi; Redha Sekhri; Irina Naguibneva; Philippe Robin; Florence Cabon; Anna Polesskaya; Annick Harel-Bellan
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

4.  Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9.

Authors:  Vesco Mutskov; Gary Felsenfeld
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

Review 5.  An epigenetic perspective on the free radical theory of development.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2007-07-10       Impact factor: 7.376

6.  Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.

Authors:  Nurit Ballas; Daniel T Lioy; Christopher Grunseich; Gail Mandel
Journal:  Nat Neurosci       Date:  2009-02-22       Impact factor: 24.884

7.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

Authors:  Quan Zhao; Gerhard Rank; Yuen T Tan; Haitao Li; Robert L Moritz; Richard J Simpson; Loretta Cerruti; David J Curtis; Dinshaw J Patel; C David Allis; John M Cunningham; Stephen M Jane
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

8.  Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.

Authors:  Thi T Nguyen; Kyucheol Cho; Sabrina A Stratton; Michelle Craig Barton
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 9.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

Review 10.  Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale?

Authors:  Graham C Burdge; Karen A Lillycrop; Alan A Jackson
Journal:  Br J Nutr       Date:  2008-12-12       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.